In addition to predicting genetic variants, the neural network was applied to predict MSI, consensus molecular subtypes and CpG island methylator phenotype in colorectal cancer as well as hormone receptor status and gene expression signatures in breast cancer. The gene discussed is NR4A1; the disease is colorectal cancer.